Skip to main content

Peer Review reports

From: Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trial

Original Submission
30 Jun 2004 Submitted Original manuscript
13 Jul 2004 Author responded Author comments - Se Hoon Park
Resubmission - Version 2
13 Jul 2004 Submitted Manuscript version 2
30 Aug 2004 Reviewed Reviewer Report - Vassilis Georgoulias
15 Nov 2004 Author responded Author comments - Se Hoon Park
Resubmission - Version 3
15 Nov 2004 Submitted Manuscript version 3
27 Jan 2005 Reviewed Reviewer Report - Vassilis Georgoulias
18 Feb 2005 Author responded Author comments - Se Hoon Park
Resubmission - Version 4
18 Feb 2005 Submitted Manuscript version 4
Publishing
22 Feb 2005 Editorially accepted
22 Feb 2005 Article published 10.1186/1471-2407-5-21

You can find further information about peer review here.

Back to article page